Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study

Circulating tumour DNA (ctDNA) is a promising biomarker that may better identify stage II colon cancer (CC) patients who will benefit from adjuvant chemotherapy (AC) compared to standard clinicopathological parameters. The DYNAMIC study demonstrated that ctDNA-informed treatment decreased AC utilisa...

Full description

Bibliographic Details
Main Authors: Yat Hang To, Peter Gibbs, Jeanne Tie, Jonathan Loree, Tamara Glyn, Koen Degeling
Format: Article
Language:English
Published: MDPI AG 2023-10-01
Series:Cancers
Subjects:
colon cancer
circulating tumour DNA
biomarker
chemotherapy
decision making
Online Access:https://www.mdpi.com/2072-6694/15/21/5227

Internet

https://www.mdpi.com/2072-6694/15/21/5227

Similar Items